COVID-19 pandemic in Tripura

Last updated

COVID-19 pandemic in Tripura
Disease COVID-19
Virus strain SARS-CoV-2
Location Tripura, India
First outbreak Wuhan, Hubei, China
Index case Agartala
Arrival date6 April 2020
(3 years, 3 months and 4 weeks) [1]
Confirmed cases1,240 (22 June 2020)
Active cases453 [note 1]
Recovered782 (22 June 2020)
Deaths
1 (9 June 2020)
Fatality rate0.08%
Government website
COVID-19 dashboard

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Tripura. The first case was recorded in this region on 6 April. [1]

Contents

Timeline

May 2020

June 2020

July 2020

August 2020

September 2020

October 2020

November 2020

December 2020

January 2021

February 2021

March 2021

April 2021

May 2021

June 2021

July 2021

August 2021

September 2021

Oct to Dec 2021

Jan to Mar 2022

April to June 2022

July to September 2022

Sample Testing

Summary of test results
Samples tested56,035
Tested Positive1,240
Tests per million [note 2] 14,037
Percentage Tested Positive2.21%
As of 22 June 2020

COVID-19 Vaccines with Approval for Emergency or Conditional Usage

Union Minister for Health & Family Welfare, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021. The Union Minister for Health & Family Welfare, Science & Technology and Earth Sciences, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021 (2).jpg
Union Minister for Health & Family Welfare, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021.

Covishield

On January 1, 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca's COVID-19 vaccine AZD1222 (marketed as Covishield). [6] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech. [7] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.

On 12 January 2021 first batches of Covishield vaccine was despatched from the Serum Institute of India. [8]

Covaxin

On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage. [9]

On 14 January 2021 first batches of Covaxin vaccine was despatched from the Bharat Biotech, albeit it was still in the third phase of testing. [10]

Others

On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG. [11] On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age. [12] [13]

On 21 October 2021, India completed administering of one billion Covid vaccines in the country. [14]

On 8 January 2022, India crossed 1.5 billion Covid vaccines milestone in the country. [15]

On 19 February 2022, India crossed 1.75 billion Covid vaccines milestone in the country. [16]

See also

Notes

  1. 4 persons migrated, are not included here
  2. Population based on 2019 estimates from National Health Mission [5]

Related Research Articles

<span class="mw-page-title-main">COVID-19 pandemic in Haryana</span> Ongoing COVID-19 viral pandemic in Haryana, India

The first case of the COVID-19 pandemic in the Indian state of Haryana was reported on 4 March 2020. The Ministry of Health and Family Welfare has confirmed a total of 2,64,955 positive cases as of 10 January 2021 out of which 2,510 are still active and 2,950 deaths so far. The recovery rate in Haryana is 97.9%.

<span class="mw-page-title-main">COVID-19 pandemic in Odisha</span> Ongoing COVID-19 viral pandemic in Odisha, India

The first case of the COVID-19 pandemic was confirmed in the Indian state of Odisha on 16 March 2020. The state has confirmed 10,00,084 cases, including 9,497 active cases, 9,83,245 recoveries, and 7,289 deaths as of 21 August 2021.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Meghalaya. The first case was recorded in this region on 14 April.

<span class="mw-page-title-main">COVID-19 pandemic in Chhattisgarh</span> Ongoing COVID-19 viral pandemic in Chhattisgarh, India

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Chhattisgarh. The first case was recorded in this region on 19 March 2020.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the Indian-administered union territory of Jammu and Kashmir. Two suspected cases with high virus load were detected and isolated on 4 March in Government Medical College, Jammu. One of them became the first confirmed positive case on 9 March 2020. Both individuals had a travel history to Iran.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Himachal Pradesh. The first case was recorded in this region on 20 March 2020.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Telangana. The first case was recorded in this region on 2 March from a man who had travel history with the UAE.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories of India including the union territory of Ladakh. The first case was recorded in this region on 18 March.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020. Slowly, the pandemic spread to various states and union territories including the state of Uttarakhand. The first case was recorded in this region on 15 March.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Chandigarh. The first case was recorded in this region on 19 March 2020. As on 24 May, total number of cases in Chandigarh was 225. This contains 43 active cases as 179 successfully recovered from it and three died from the virus.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Andaman and Nicobar Islands. The first case was recorded in this region on 26 March 2020. The islands have pursued a strategy of zero COVID-19 transmission, which, except for three flareups in August 2020, May 2021, and January 2022, which were swiftly contained, have resulted in no community outbreaks. The islands have successfully managed the outbreaks, and the union territory has the lowest case count of any region of India, both in total cases and infection rate.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Puducherry. The first case was recorded in this region on 17 March.

The COVID-19 pandemic reached the state of Nagaland on 22 May 2020, with its first case confirmed on 25 May 2020. Officially, Nagaland is the last of the northeastern states after Sikkim to report COVID-19 positive cases.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Manipur. The first case was recorded in this region on 24 March 2020.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Arunachal Pradesh. The first case was recorded in this region on 2 April 2020.

<span class="mw-page-title-main">COVID-19 pandemic in Mizoram</span> Ongoing COVID-19 viral pandemic in Mizoram, India

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Mizoram. The first case was recorded in this region on 24 March 2020, and the first death was recorded on 28 October 2020.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Dadra and Nagar Haveli and Daman and Diu. The first case was recorded in this region on 10 April 2020.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Sikkim.

<span class="mw-page-title-main">COVID-19 vaccination in India</span> Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.

<span class="mw-page-title-main">Vaccine Maitri</span> Vaccination initiative by the Indian government

Vaccine Maitri is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. The government started providing vaccines from 20 January 2021. As of 21 February 2022, India had delivered around 16.29 crore doses of vaccines to 96 countries. Of these, 1.43 cror doses were gifted to 98 countries by the Government of India. The remaining 10.71 crore were supplied by the vaccine producers under its commercial and 4.15 crore were supplied by COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines. The Health Minister of India, Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world.

References

  1. 1 2 Loiwal, Manogya (6 April 2020). "Coronavirus in India: Woman tests positive for Covid-19 in Agartala, first case in Tripura". India Today. Retrieved 14 May 2020.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 "MoHFW-GOI". Ministry of Health and Family Welfare . Retrieved 23 May 2020.
  3. Ali, Syed Sajjad (27 August 2020). "Tripura surpasses 10,000 coronavirus cases". The Hindu. Retrieved 2 September 2020.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 "COVID19 STATEWISE STATUS". MyGov.in. 28 March 2020. Retrieved 14 December 2021.
  5. "Report_Population_Projection_2019.pdf" (PDF). NHM India. Retrieved 19 June 2020.
  6. "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 4 January 2021.
  7. "AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK". AstraZeneca. AstraZeneca. 30 December 2020. Retrieved 4 January 2021.
  8. "Stand By, India: Serum Institute Sends Out Vaccines, 1st Batch In Delhi". NDTV. 12 January 2021. Retrieved 12 January 2021.
  9. "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 4 January 2021.
  10. "Covaxin delivery starts, 'full initial procurement allotted'". Indian Express. 14 January 2021. Retrieved 14 January 2021.
  11. "Dr Reddy's confirms Emergency Use Authorisation for anti-COVID drug 2-DG, says price not yet fixed". Moneycontol. 19 May 2021. Retrieved 20 May 2021.
  12. "Approval granted to COVID vaccine Corbevax for children between 12-18 years". Times of India. 21 February 2022. Retrieved 22 February 2022.
  13. "Biological E's Covid vaccine Corbevax receives emergency use nod for children aged 12-18 yrs". Hindustan Times. 21 February 2022. Retrieved 22 February 2022.
  14. "India scripts history, administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021.
  15. "India crosses 1.5 bn Covid vaccine doses, Modi terms it 'significant milestone'". Hindustan Times. 9 January 2022. Retrieved 16 January 2022.
  16. "COVID-19: India's vaccination coverage crosses 175 crore mark". DNA India. 19 February 2022. Retrieved 26 February 2022.

COVID-19 tracker